Vishal Bhatnagar, MD
@vishalbmd
Associate Director for Patient Outcomes, Oncology Center of Excellence. FDA. Interested in MM and patient focused drug development. Opinions/tweets are my own
ID: 935170815577948166
27-11-2017 15:37:51
40 Tweet
258 Followers
123 Following
Patient-reported overall side effect bother is key to assessing tolerability. Listen to Paul Kluetz moderate a discussion w/ Laura Fernandes Gita Thanarajasingam Janet Freeman-Daily Sandra Spivey Preeti Narayan, MD, Dr Sandra Mitchell and Dr David Cella. Tune in now! #OCEOutcomes20